Authors:
Falco, C
Tormo, G
Estelles, A
Espana, F
Tormo, E
Gilabert, J
Velasco, JA
Aznar, J
Citation: C. Falco et al., Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy, HAEMATOLOG, 86(1), 2001, pp. 92-98
Authors:
Estelles, A
Dalmou, J
Falco, C
Berbel, O
Castello, R
Espana, F
Aznar, J
Citation: A. Estelles et al., Plasma PAI-1 levels in obese children - Effect of weight loss and influence of PAI-1 promoter 4G/5G genotype, THROMB HAEM, 86(2), 2001, pp. 647-652
Authors:
Segui, R
Estelles, A
Mira, Y
Espana, F
Villa, P
Falco, C
Vaya, A
Grancha, S
Ferrando, F
Aznar, J
Citation: R. Segui et al., PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects, BR J HAEM, 111(1), 2000, pp. 122-128
Authors:
Grancha, S
Estelles, A
Tormo, G
Falco, C
Gilabert, J
Espana, F
Cano, A
Segui, R
Aznar, J
Citation: S. Grancha et al., Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary arterydisease - Influence of hormone replacement therapy, THROMB HAEM, 81(4), 1999, pp. 516-521
Authors:
Estelles, A
Cano, A
Falco, C
Espana, F
Gilabert, J
Grancha, S
Aznar, J
Citation: A. Estelles et al., Lipoprotein(a) levels and isoforms and fibrinolytic activity in postmenopause - Influence of hormone replacement therapy, THROMB HAEM, 81(1), 1999, pp. 104-110